| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 66 | 2025 | 1130 | 5.340 |
Why?
|
| CpG Islands | 37 | 2025 | 345 | 3.120 |
Why?
|
| Epigenesis, Genetic | 22 | 2025 | 757 | 2.930 |
Why?
|
| Colorectal Neoplasms | 17 | 2025 | 629 | 2.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 7 | 2024 | 114 | 1.770 |
Why?
|
| Carcinogenesis | 4 | 2024 | 359 | 1.560 |
Why?
|
| Colonic Neoplasms | 9 | 2023 | 264 | 1.270 |
Why?
|
| Promoter Regions, Genetic | 17 | 2015 | 1294 | 0.880 |
Why?
|
| Gene Silencing | 13 | 2012 | 240 | 0.880 |
Why?
|
| Gene Expression Regulation, Neoplastic | 18 | 2025 | 2064 | 0.870 |
Why?
|
| Intestinal Neoplasms | 1 | 2024 | 40 | 0.830 |
Why?
|
| DNA | 5 | 2021 | 1483 | 0.710 |
Why?
|
| Embryonic Stem Cells | 4 | 2013 | 173 | 0.590 |
Why?
|
| Microbiota | 2 | 2021 | 434 | 0.570 |
Why?
|
| Polymerase Chain Reaction | 10 | 2009 | 1554 | 0.510 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2024 | 634 | 0.510 |
Why?
|
| DNA-Binding Proteins | 10 | 2021 | 1997 | 0.480 |
Why?
|
| Cell Differentiation | 6 | 2015 | 1975 | 0.460 |
Why?
|
| Mutation | 11 | 2017 | 6248 | 0.440 |
Why?
|
| Microsatellite Repeats | 6 | 2011 | 236 | 0.420 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 430 | 0.410 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2009 | 127 | 0.410 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 810 | 0.410 |
Why?
|
| Nuclear Proteins | 9 | 2012 | 1285 | 0.410 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2013 | 1046 | 0.400 |
Why?
|
| Mice | 18 | 2024 | 18565 | 0.400 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2009 | 493 | 0.390 |
Why?
|
| Intestinal Mucosa | 6 | 2015 | 796 | 0.370 |
Why?
|
| Biomarkers, Tumor | 7 | 2025 | 1683 | 0.360 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2013 | 1019 | 0.360 |
Why?
|
| Intestines | 1 | 2015 | 606 | 0.350 |
Why?
|
| Cell Line, Tumor | 21 | 2014 | 3698 | 0.340 |
Why?
|
| Stem Cells | 1 | 2015 | 732 | 0.330 |
Why?
|
| Neoplasm Proteins | 6 | 2009 | 701 | 0.320 |
Why?
|
| Gene Expression Profiling | 8 | 2010 | 1879 | 0.300 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 1425 | 0.300 |
Why?
|
| Humans | 70 | 2025 | 132083 | 0.300 |
Why?
|
| DNA, Neoplasm | 8 | 2009 | 296 | 0.290 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 4 | 2015 | 158 | 0.290 |
Why?
|
| DNA Modification Methylases | 4 | 2021 | 51 | 0.280 |
Why?
|
| Azacitidine | 6 | 2009 | 53 | 0.280 |
Why?
|
| Animals | 19 | 2024 | 34951 | 0.280 |
Why?
|
| Folic Acid | 3 | 2024 | 290 | 0.270 |
Why?
|
| Fluorouracil | 1 | 2007 | 139 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2021 | 615 | 0.270 |
Why?
|
| Neoplasms | 9 | 2021 | 2952 | 0.260 |
Why?
|
| Lung Neoplasms | 5 | 2020 | 1540 | 0.260 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2009 | 773 | 0.260 |
Why?
|
| Colon | 5 | 2010 | 370 | 0.250 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 2 | 2005 | 19 | 0.250 |
Why?
|
| Histones | 7 | 2021 | 538 | 0.250 |
Why?
|
| Aged | 22 | 2025 | 21404 | 0.240 |
Why?
|
| Temperature | 1 | 2007 | 305 | 0.240 |
Why?
|
| Long Interspersed Nucleotide Elements | 4 | 2010 | 37 | 0.240 |
Why?
|
| Adenoma | 4 | 2010 | 145 | 0.230 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 2444 | 0.230 |
Why?
|
| Brain Neoplasms | 2 | 2025 | 1411 | 0.230 |
Why?
|
| Middle Aged | 27 | 2025 | 28922 | 0.230 |
Why?
|
| Male | 37 | 2025 | 64904 | 0.230 |
Why?
|
| Genomic Structural Variation | 1 | 2025 | 92 | 0.220 |
Why?
|
| Melanoma | 2 | 2009 | 954 | 0.210 |
Why?
|
| Genome, Human | 4 | 2011 | 1332 | 0.210 |
Why?
|
| Sulfites | 4 | 2014 | 30 | 0.210 |
Why?
|
| Female | 35 | 2025 | 70664 | 0.210 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 816 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 7 | 2014 | 1803 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 454 | 0.200 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2003 | 12 | 0.200 |
Why?
|
| Age of Onset | 1 | 2025 | 626 | 0.200 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2003 | 31 | 0.200 |
Why?
|
| Lysine | 4 | 2008 | 190 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 816 | 0.200 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 86 | 0.190 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2002 | 66 | 0.190 |
Why?
|
| Antineoplastic Agents | 4 | 2010 | 1828 | 0.190 |
Why?
|
| Cyclins | 1 | 2002 | 100 | 0.190 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 126 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2025 | 5148 | 0.180 |
Why?
|
| Epigenomics | 2 | 2021 | 190 | 0.180 |
Why?
|
| Liver | 1 | 2009 | 1801 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2009 | 987 | 0.180 |
Why?
|
| Diet | 2 | 2024 | 1124 | 0.180 |
Why?
|
| Adult | 18 | 2025 | 31544 | 0.170 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2007 | 195 | 0.170 |
Why?
|
| Aging | 3 | 2017 | 1253 | 0.170 |
Why?
|
| Genome | 2 | 2021 | 502 | 0.170 |
Why?
|
| Cell Cycle | 1 | 2003 | 611 | 0.170 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 2 | 2012 | 8 | 0.160 |
Why?
|
| Dysbiosis | 1 | 2021 | 139 | 0.160 |
Why?
|
| Environmental Exposure | 1 | 2002 | 234 | 0.160 |
Why?
|
| Infant Nutrition Disorders | 1 | 2019 | 15 | 0.160 |
Why?
|
| Duodenum | 1 | 2019 | 113 | 0.150 |
Why?
|
| Celiac Disease | 1 | 2019 | 73 | 0.150 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 688 | 0.140 |
Why?
|
| Cell Line | 5 | 2013 | 2730 | 0.140 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 2 | 2015 | 25 | 0.140 |
Why?
|
| Base Sequence | 8 | 2011 | 2902 | 0.140 |
Why?
|
| Aged, 80 and over | 10 | 2012 | 7119 | 0.130 |
Why?
|
| Malnutrition | 1 | 2019 | 161 | 0.130 |
Why?
|
| Machine Learning | 1 | 2020 | 347 | 0.130 |
Why?
|
| Adenocarcinoma | 3 | 2009 | 1017 | 0.130 |
Why?
|
| Hedgehog Proteins | 2 | 2015 | 263 | 0.130 |
Why?
|
| Phenotype | 8 | 2010 | 4541 | 0.120 |
Why?
|
| Animals, Suckling | 1 | 2015 | 51 | 0.120 |
Why?
|
| Aurora Kinase C | 1 | 2015 | 2 | 0.120 |
Why?
|
| Liver Neoplasms | 3 | 2011 | 1386 | 0.110 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2010 | 540 | 0.110 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2014 | 33 | 0.110 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 86 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 1292 | 0.110 |
Why?
|
| Methylation | 2 | 2013 | 216 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2007 | 210 | 0.110 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2013 | 35 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2010 | 571 | 0.100 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2013 | 59 | 0.100 |
Why?
|
| CCCTC-Binding Factor | 1 | 2013 | 20 | 0.100 |
Why?
|
| Genes, Neoplasm | 3 | 2008 | 88 | 0.100 |
Why?
|
| Rectum | 2 | 2010 | 114 | 0.100 |
Why?
|
| Testis | 1 | 2015 | 423 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 5 | 2010 | 1047 | 0.100 |
Why?
|
| Chromatin | 3 | 2021 | 521 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2014 | 615 | 0.090 |
Why?
|
| Chromosome Mapping | 3 | 2014 | 1097 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2013 | 210 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2512 | 0.090 |
Why?
|
| Organ Specificity | 2 | 2010 | 413 | 0.090 |
Why?
|
| Algorithms | 2 | 2020 | 1724 | 0.090 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2012 | 357 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2008 | 2679 | 0.090 |
Why?
|
| DNA Repair Enzymes | 2 | 2008 | 43 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2851 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2009 | 86 | 0.080 |
Why?
|
| Retinoblastoma Protein | 2 | 2008 | 83 | 0.080 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 228 | 0.080 |
Why?
|
| Retroelements | 1 | 2010 | 40 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2013 | 815 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 3778 | 0.080 |
Why?
|
| Frameshift Mutation | 1 | 2011 | 201 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2007 | 71 | 0.080 |
Why?
|
| Apoptosis | 2 | 2007 | 1904 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2010 | 44 | 0.080 |
Why?
|
| Disease-Free Survival | 2 | 2009 | 955 | 0.080 |
Why?
|
| DNA Primers | 5 | 2010 | 637 | 0.080 |
Why?
|
| Inflammation | 1 | 2017 | 1521 | 0.080 |
Why?
|
| Hydroxamic Acids | 2 | 2007 | 60 | 0.080 |
Why?
|
| Genetics, Medical | 1 | 2010 | 121 | 0.080 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2009 | 84 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3377 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2009 | 33 | 0.080 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 134 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 187 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2010 | 361 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 4764 | 0.080 |
Why?
|
| Butyrates | 1 | 2009 | 42 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 311 | 0.070 |
Why?
|
| Sp3 Transcription Factor | 1 | 2008 | 7 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2009 | 1367 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 42 | 0.070 |
Why?
|
| ras Proteins | 2 | 2008 | 146 | 0.070 |
Why?
|
| Genes, APC | 1 | 2008 | 13 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 292 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 2009 | 80 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 945 | 0.070 |
Why?
|
| Centrosome | 1 | 2008 | 27 | 0.070 |
Why?
|
| Mesothelioma | 1 | 2009 | 93 | 0.070 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2008 | 4 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2008 | 803 | 0.070 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2008 | 174 | 0.070 |
Why?
|
| Colitis | 1 | 2010 | 164 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2017 | 4725 | 0.070 |
Why?
|
| Prostate | 2 | 2008 | 437 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2012 | 2494 | 0.070 |
Why?
|
| Chromosomal Instability | 1 | 2008 | 61 | 0.070 |
Why?
|
| Tumor Protein p73 | 1 | 2007 | 27 | 0.070 |
Why?
|
| Breast Neoplasms | 4 | 2008 | 2682 | 0.070 |
Why?
|
| Drug Tolerance | 1 | 2007 | 40 | 0.070 |
Why?
|
| Leucovorin | 1 | 2007 | 54 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 111 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 2141 | 0.070 |
Why?
|
| Survival Rate | 2 | 2009 | 2184 | 0.070 |
Why?
|
| Dinucleoside Phosphates | 1 | 2006 | 11 | 0.070 |
Why?
|
| Sulfates | 1 | 2007 | 35 | 0.070 |
Why?
|
| Receptors, Estrogen | 2 | 2009 | 741 | 0.070 |
Why?
|
| Enzyme Inhibitors | 3 | 2009 | 589 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2008 | 172 | 0.060 |
Why?
|
| Multigene Family | 1 | 2007 | 305 | 0.060 |
Why?
|
| Genomic Imprinting | 1 | 2007 | 130 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 186 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 246 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 3358 | 0.060 |
Why?
|
| MutL Protein Homolog 1 | 4 | 2008 | 52 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2009 | 278 | 0.060 |
Why?
|
| Cisplatin | 1 | 2007 | 281 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2008 | 679 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2007 | 365 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2006 | 46 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2006 | 102 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2007 | 1085 | 0.060 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2025 | 39 | 0.060 |
Why?
|
| Adolescent | 6 | 2025 | 20532 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2006 | 295 | 0.060 |
Why?
|
| Prostatic Neoplasms | 3 | 2008 | 1577 | 0.060 |
Why?
|
| Microarray Analysis | 3 | 2010 | 237 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 1246 | 0.060 |
Why?
|
| X-linked Nuclear Protein | 1 | 2024 | 18 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 1838 | 0.060 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2024 | 66 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 295 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2007 | 217 | 0.050 |
Why?
|
| Germ Cells | 1 | 2025 | 204 | 0.050 |
Why?
|
| Child | 5 | 2025 | 25761 | 0.050 |
Why?
|
| Genes, ras | 2 | 2017 | 100 | 0.050 |
Why?
|
| Telomerase | 1 | 2024 | 168 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2003 | 13 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2010 | 917 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 681 | 0.050 |
Why?
|
| Disease Progression | 4 | 2014 | 2224 | 0.050 |
Why?
|
| Genes, p53 | 3 | 2009 | 222 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 210 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2003 | 86 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 2009 | 566 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2025 | 368 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 86 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2009 | 13014 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 214 | 0.050 |
Why?
|
| Sample Size | 1 | 2002 | 88 | 0.050 |
Why?
|
| Aflatoxins | 1 | 2002 | 3 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 541 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2002 | 142 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2002 | 137 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2008 | 623 | 0.050 |
Why?
|
| Hepatitis | 1 | 2002 | 58 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2006 | 720 | 0.050 |
Why?
|
| Carcinogens | 1 | 2002 | 129 | 0.050 |
Why?
|
| Risk Factors | 3 | 2009 | 10899 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 54 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 897 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 36 | 0.040 |
Why?
|
| Prognosis | 3 | 2010 | 5006 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2021 | 222 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 157 | 0.040 |
Why?
|
| Fibrosis | 1 | 2002 | 428 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 727 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 2 | 2010 | 79 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 825 | 0.040 |
Why?
|
| Pakistan | 1 | 2019 | 94 | 0.040 |
Why?
|
| Growth | 1 | 2019 | 96 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2003 | 1569 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2025 | 14719 | 0.040 |
Why?
|
| Young Adult | 2 | 2010 | 9935 | 0.040 |
Why?
|
| Patient Selection | 1 | 2002 | 731 | 0.040 |
Why?
|
| Colonic Polyps | 2 | 2010 | 83 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2009 | 236 | 0.040 |
Why?
|
| Cause of Death | 1 | 2020 | 500 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2019 | 191 | 0.040 |
Why?
|
| LIM Domain Proteins | 2 | 2008 | 64 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2007 | 3714 | 0.030 |
Why?
|
| Karyotyping | 2 | 2008 | 319 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2019 | 294 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2008 | 223 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2009 | 3417 | 0.030 |
Why?
|
| RNA, Untranslated | 2 | 2009 | 114 | 0.030 |
Why?
|
| Infant | 3 | 2019 | 13040 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2009 | 222 | 0.030 |
Why?
|
| HCT116 Cells | 2 | 2007 | 61 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2010 | 1653 | 0.030 |
Why?
|
| Acetylation | 2 | 2008 | 191 | 0.030 |
Why?
|
| Carrier Proteins | 3 | 2007 | 1050 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1289 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 2 | 2010 | 439 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 5399 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2015 | 28 | 0.030 |
Why?
|
| Research Design | 1 | 2019 | 743 | 0.030 |
Why?
|
| RNA, Long Noncoding | 2 | 2009 | 241 | 0.030 |
Why?
|
| COUP Transcription Factor II | 1 | 2015 | 98 | 0.030 |
Why?
|
| Cilia | 1 | 2015 | 79 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 573 | 0.030 |
Why?
|
| Texas | 1 | 2002 | 3632 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 143 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 2922 | 0.030 |
Why?
|
| Genomics | 2 | 2014 | 1651 | 0.020 |
Why?
|
| beta Catenin | 1 | 2014 | 228 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1758 | 0.020 |
Why?
|
| Time Factors | 1 | 2003 | 6445 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 3020 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 880 | 0.020 |
Why?
|
| Genotype | 1 | 2018 | 2706 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2012 | 34 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2012 | 56 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2012 | 65 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2010 | 1596 | 0.020 |
Why?
|
| Gambia | 1 | 2010 | 26 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 336 | 0.020 |
Why?
|
| Fertilization | 1 | 2010 | 43 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2010 | 88 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 235 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 127 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2010 | 54 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1034 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 98 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2010 | 58 | 0.020 |
Why?
|
| Tretinoin | 1 | 2010 | 102 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2009 | 37 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2009 | 57 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 119 | 0.020 |
Why?
|
| Vitamin B 6 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Seasons | 1 | 2010 | 328 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 288 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 33 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 96 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 323 | 0.020 |
Why?
|
| Rural Population | 1 | 2010 | 242 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2008 | 9 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 161 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 69 | 0.020 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2008 | 29 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 123 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2008 | 47 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 96 | 0.020 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2008 | 67 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 365 | 0.020 |
Why?
|
| Urothelium | 1 | 2008 | 60 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 179 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 578 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2009 | 201 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 143 | 0.020 |
Why?
|
| Aspirin | 1 | 2009 | 221 | 0.020 |
Why?
|
| Methyltransferases | 1 | 2008 | 82 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 750 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 32 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 598 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 130 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 475 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1008 | 0.020 |
Why?
|
| Remission Induction | 1 | 2007 | 307 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 97 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2007 | 26 | 0.020 |
Why?
|
| Friedreich Ataxia | 1 | 2007 | 48 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2006 | 180 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4694 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2009 | 248 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2008 | 257 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2007 | 133 | 0.020 |
Why?
|
| Telomere | 1 | 2008 | 222 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2006 | 46 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2007 | 111 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 359 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 343 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 761 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 285 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2007 | 92 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2006 | 7 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8539 | 0.020 |
Why?
|
| Life Style | 1 | 2009 | 452 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 81 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 383 | 0.020 |
Why?
|
| Cadherins | 1 | 2007 | 180 | 0.020 |
Why?
|
| Quinazolines | 1 | 2006 | 187 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2009 | 439 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 764 | 0.010 |
Why?
|
| Mesoderm | 1 | 2006 | 110 | 0.010 |
Why?
|
| Binding Sites | 1 | 2008 | 1256 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 443 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 796 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 691 | 0.010 |
Why?
|
| Leukemia | 1 | 2008 | 373 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2009 | 413 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 873 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 1454 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 605 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 549 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1118 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1967 | 0.010 |
Why?
|
| Smoking | 1 | 2009 | 941 | 0.010 |
Why?
|
| Neurons | 1 | 2013 | 2016 | 0.010 |
Why?
|
| DNA Repair | 1 | 2007 | 567 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 619 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 444 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 1161 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1672 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1351 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 3061 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 3612 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1722 | 0.010 |
Why?
|
| Palliative Care | 1 | 2006 | 457 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 903 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 1132 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 6530 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 2152 | 0.010 |
Why?
|